Case Report
A 75-year-old African American woman presented to the clinic with a history of a slowly growing asymptomatic nodule on the right anterior scalp over a few months. Physical exam revealed a hyperpigmented, grey to black, solitary nodule of the right anterior frontal scalp with no secondary epidermal changes (Figure 1). She denied any personal or family history of skin, visceral, or hematologic cancers. Punch biopsy was done for further evaluation and gross specimen demonstrated a solid black dermal mass.
What Is The Diagnosis?
Check your answer by hitting "Next" below!
,
Diagnosis: Pigmented epithelioid melanocytoma
Pigmented epithelioid melanocytoma (PEM) is a term proposed by Zembowicz et al1 in 2004 to describe heavily pigmented melanocytic tumors ranging from epithelioid blue nevi to animal-type melanoma. PEM is considered by some a low-grade type of melanoma that has an indolent course and rare visceral metastatis.1 Histologically, there is no characteristic to differentiate metastasizing vs nonmetastasizing PEMs.1,2 PEM shows no ethnic or gender predilection.1 Involvement of areas such as genitals and mucosa suggest that sun exposure is not a risk factor in the pathogenesis of PEM.1
Clinical Presentation
PEM most commonly presents as a slow growing, blue to black nodule on an extremity. However, they also commonly appear on the trunk, head, and neck.3 PEMs typically arise sporadically but have also been reported in association with preexisting dermal or congenital nevi that expanded in later years.1,3 PEM has a predilection for children, adolescents, and young adults and has a more indolent course in younger patients.1,4 The median age is 27 years, though reports of presentation range from newborn to age 92 years.3 It has a high tendency to involve regional lymph nodes and rarely results in distant metastases or death.1,4
Dermoscopic examination of PEM reveals a combination of homogeneous blue pigment, black and blue pigment, brown comedo-like openings, white pigment representing crystalline structures, and blue pigment extending into lymphatic vessels.5
Pathologic Findings
Histopathologically, PEM is a dermal melanocytic proliferation of pigmented epithelioid and spindled melanocytes.3,4 The overlying epidermis is often hyperplastic and a Grenz zone may be present. Mitoses and cytological atypia are variable and necrosis is not seen. Immunohistochemistry will demonstrate a positive S-100, vimentin, HMB-45, and Melan-A.
Differential Diagnosis
Please refer to the Table2,3,6-12 for the differential diagnosis of PEM.
Management
PEM is a low-grade melanocytic tumor that usually has a favorable long-term clinical outcome.13 In a 67-month study of 26 patients who underwent complete local excision and were subsequently monitored, none of them had adverse outcomes, including those with sentinel lymph node metastasis.13 There is no histologic criteria to differentiate metastasizing vs nonmetastasizing PEMs.1 Treatment of PEM includes excising the lesion with clear margins to reduce the possibility of recurrence.13 Sentinel lymph node biopsy may not be necessary because the presence of lymph node metastasis does not appear to affect the prognosis. Given the favorable clinical course of PEM, it is not justified to treat patients with biologic or chemotherapeutic agents.13
Our Patient
The grey-black hyperpigmented nodule found on our patient’s anterior scalp was asymptomatic (Figure 1). The lesion was biopsied for diagnosis and definitively excised with 1-mm margins. Punch biopsy of this patient’s lesion revealed a dermal proliferation of plump epithelioid cells with cytoplasmic pigmentation, mild nuclear atypia, and no mitosis (Figures 2, 3). The epithelioid cells were distributed between collagen bundles and along adnexal structures with extension into the subcutaneous fat. Dermoscopy demonstrated a homogenous bluish grey and black pigmentation with no crystalline structures or irregular pigmentation networks. The patient showed no signs of recurrence at 1-month follow up.
Conclusion
We present a case of PEM on the scalp. It most commonly presents as a black or blue nodule on the extremity of a young adult. The differential diagnosis for a black or blue nodule is broad, the most concerning being nodular melanoma, therefore diagnosis is typically confirmed by biopsy. Treatment includes local excision with clear margins to reduce the likelihood of recurrence. Although rare, visceral metastasis can occur, making it essential for patients to undergo complete excision and close follow-up.
,
Ms Grayson is from Florida State University College of Medicine in Tallahassee, FL. Drs Richardson and Heidelberg are from St. Joseph Mercy Health System in Ypsilanti, MI.
References
1. Zembowicz A, Carney JA, Mihm MC. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from ani- mal-type melanoma and epithelioid blue nevus. Am J Surg Pathol. 2004;28(1):31-40. doi:10.1097/00000478-200401000-00002
2. Zembowicz A, Phadke PA. Blue nevi and variants: an update. Arch Pathol Lab Med. 2011;135(3):327-336. doi:10.1043/2009-0733-RA.1
3. Vyas R, Keller JJ, Honda K, Cooper KD, Gerstenblith MR. A systematic review and meta-analysis of animal-type melanoma. J Am Acad Dermatol. 2015;73(6):1031-1039. doi:10.1016/j.jaad.2015.08.016
4. Ludgate MW, Fullen DR, Lee J, et al. Animal-type melanoma: a clinical and histopath- ological study of 22 cases from a single institution. Br J Dermatol. 2010;162(1):129-136. doi:10.1111/j.1365-2133.2009.09271.x
5. Moscarella E, Ricci R, Argenziano G, et al. Pigmented epithelioid melanocytoma: clinical, dermoscopic and histopathological features. Br J Dermatol. 2016;174(5):1115-1117. doi:10.1111/bjd.14322
6. Kalkhoran S, Milne O, Zalaudek I, et al. Historical, clinical, and dermoscopic char- acteristics of thin nodular melanoma. Arch Dermatol. 2010;146(3):311-318. doi:10.1001/ archdermatol.2009.369
7. Smoller, BR. Histologic criteria for diagnosing primary cutaneous malignant melano- ma. Mod Pathol. 2006;19(suppl 2):S34-S40. doi:10.1038/modpathol.3800508
8. Antony FC, Sanclemente G, Shaikh H, Trelles AS, Calonje E. Pigment synthesizing melanoma (so-called animal type melanoma): a clinicopathological study of 14 cases of a poorly known distinctive variant of melanoma. Histopathology. 2006;48(6):754-762. doi:10.1111/j.1365-2559-2006.02411.x
9. Ribé A, McNutt NS. S100A6 protein expression is different in Spitz nevi and melano- mas. Mod Pathol. 2003;16(5):505-511. doi:10.1097/01.MP.0000071128.67149.FD
10. Laureano A, Fernandes C, Cardoso J. Hemosiderotic dermatofibroma: clinical and dermoscopic presentation mimicking melanoma. J Dermatol Case Rep. 2015;9(2):39-41. doi:10.3315/jdcr.2015.1198
11. Alves JV, Matos DM, Barreiros HF, Bartolo EA. Variants of dermatofibroma-a his- topathological study. An Bras Dermatol. 2014;89(3):472-477. doi:10.1590/abd1806- 4841.20142629
12. Ferringer T. Immunohistochemistry in dermatopathology. Arch Pathol Lab Med. 2015;139(1):83-105. doi:10.5858/arpa.2014-0075-RA
13. Mandal RV, Murali R, Lundquist KF, et al. Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up. Am J Surg Pathol. 2009;33(12):1778-1782. doi:10.1097/PAS.0b013e3181b94f3c
The Dermatology Nurses' Association (DNA) announced that it will host its first virtual symposium on Saturday, November 10, 2012. The virtual symposium, which will focus on psoriasis, will offer a unique educational format for dermatology and...
The Dermatology Nurses' Association (DNA) announced that it will host its first virtual symposium on Saturday, November 10, 2012. The virtual symposium, which will focus on psoriasis, will offer a unique educational format for dermatology and...
The FDA has approved the non-invasive fat destruction device, UltraShape Power (Syneron Candela) for the non-invasive reduction of abdominal circumference via fat cell destruction.
The FDA has approved the non-invasive fat destruction device, UltraShape Power (Syneron Candela) for the non-invasive reduction of abdominal circumference via fat cell destruction.
Maximize Social Media, LLC, a social media management firm with offices in Florida and California, has announced a new dermatology marketing program.The firm will provide dermatologists with management of the top social media platforms,...
Maximize Social Media, LLC, a social media management firm with offices in Florida and California, has announced a new dermatology marketing program.The firm will provide dermatologists with management of the top social media platforms,...
Researchers at the Karolinska Institute in Sweden have described the stratum corneum at a molecular level, a novel understanding of the outermost layer of the skin that could lead to significant treatment breakthroughs.The researchers...
Researchers at the Karolinska Institute in Sweden have described the stratum corneum at a molecular level, a novel understanding of the outermost layer of the skin that could lead to significant treatment breakthroughs.The researchers...
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?